Annual Current Liabilities
$19.14 M
-$2.81 M-12.81%
31 December 2023
Summary:
Viking Therapeutics annual total current liabilities is currently $19.14 million, with the most recent change of -$2.81 million (-12.81%) on 31 December 2023. During the last 3 years, it has risen by +$7.01 million (+57.76%). VKTX annual current liabilities is now -15.02% below its all-time high of $22.52 million, reached on 31 December 2014.VKTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$25.68 M
+$592.00 K+2.36%
30 September 2024
Summary:
Viking Therapeutics quarterly total current liabilities is currently $25.68 million, with the most recent change of +$592.00 thousand (+2.36%) on 30 September 2024. Over the past year, it has increased by +$12.28 million (+91.61%). VKTX quarterly current liabilities is now -21.63% below its all-time high of $32.77 million, reached on 31 March 2024.VKTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.8% | +91.6% |
| 3 y3 years | +57.8% | +126.2% |
| 5 y5 years | +320.6% | +314.8% |
VKTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -12.8% | +118.0% | -21.6% | +192.6% |
| 5 y | 5 years | -12.8% | +320.6% | -21.6% | +314.8% |
| alltime | all time | -15.0% | >+9999.0% | -21.6% | +5787.0% |
Viking Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.68 M(+2.4%) |
| June 2024 | - | $25.09 M(-23.4%) |
| Mar 2024 | - | $32.77 M(+71.3%) |
| Dec 2023 | $19.14 M(-12.8%) | $19.14 M(+42.7%) |
| Sept 2023 | - | $13.40 M(-0.5%) |
| June 2023 | - | $13.48 M(-13.9%) |
| Mar 2023 | - | $15.65 M(-28.7%) |
| Dec 2022 | $21.95 M(+150.0%) | $21.95 M(+56.1%) |
| Sept 2022 | - | $14.06 M(-5.4%) |
| June 2022 | - | $14.86 M(+31.9%) |
| Mar 2022 | - | $11.27 M(+28.4%) |
| Dec 2021 | $8.78 M(-27.6%) | $8.78 M(-22.7%) |
| Sept 2021 | - | $11.35 M(-11.8%) |
| June 2021 | - | $12.87 M(-0.3%) |
| Mar 2021 | - | $12.92 M(+6.5%) |
| Dec 2020 | $12.13 M(+79.0%) | $12.13 M(+24.8%) |
| Sept 2020 | - | $9.71 M(+7.3%) |
| June 2020 | - | $9.05 M(+6.0%) |
| Mar 2020 | - | $8.54 M(+26.0%) |
| Dec 2019 | $6.78 M | $6.78 M(+9.4%) |
| Sept 2019 | - | $6.19 M(+10.1%) |
| June 2019 | - | $5.63 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $4.92 M(+8.1%) |
| Dec 2018 | $4.55 M(-47.4%) | $4.55 M(-4.1%) |
| Sept 2018 | - | $4.74 M(+15.5%) |
| June 2018 | - | $4.11 M(-35.2%) |
| Mar 2018 | - | $6.34 M(-26.8%) |
| Dec 2017 | $8.66 M(+33.7%) | $8.66 M(-9.9%) |
| Sept 2017 | - | $9.61 M(+24.4%) |
| June 2017 | - | $7.73 M(+128.5%) |
| Mar 2017 | - | $3.38 M(-47.8%) |
| Dec 2016 | $6.48 M(+227.6%) | $6.48 M(+6.6%) |
| Sept 2016 | - | $6.08 M(+5.9%) |
| June 2016 | - | $5.74 M(+199.2%) |
| Mar 2016 | - | $1.92 M(-3.0%) |
| Dec 2015 | $1.98 M(-91.2%) | $1.98 M(-65.5%) |
| Sept 2015 | - | $5.72 M(+17.4%) |
| June 2015 | - | $4.88 M(-82.4%) |
| Mar 2015 | - | $27.71 M(+23.1%) |
| Dec 2014 | $22.52 M(>+9900.0%) | $22.52 M(-6.1%) |
| June 2014 | - | $23.97 M(+5393.5%) |
| Mar 2014 | - | $436.30 K |
| Dec 2013 | $127.50 K(+134.4%) | - |
| Dec 2012 | $54.40 K | - |
FAQ
- What is Viking Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual current liabilities year-on-year change?
- What is Viking Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly current liabilities year-on-year change?
What is Viking Therapeutics annual total current liabilities?
The current annual current liabilities of VKTX is $19.14 M
What is the all time high annual current liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total current liabilities is $22.52 M
What is Viking Therapeutics annual current liabilities year-on-year change?
Over the past year, VKTX annual total current liabilities has changed by -$2.81 M (-12.81%)
What is Viking Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VKTX is $25.68 M
What is the all time high quarterly current liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total current liabilities is $32.77 M
What is Viking Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VKTX quarterly total current liabilities has changed by +$12.28 M (+91.61%)